balance equationreview2025-06-30
Difference 1162806000 exceeds tolerance 26241363.000. Presentation or filing-vintage differences need review.
Revenue
$2.58B
Fiscal year ended 2026-06-30Operating income
-$49.00M
Fiscal year ended 2026-06-30Free cash flow
-$5.74B
Fiscal year ended 2026-06-30CoreWeave, Inc. (CRWV) reported revenue of $2.58B and net income of -$626.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CoreWeave, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Prepackaged Software.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.58B | $2.08B | $1.57B | $1.36B | $1.21B | $982.00M | $747.00M | $583.94M | $395.37M | $188.68M |
| Cost of revenue | $879.00M | $716.00M | $509.12M | $368.82M | $313.00M | $262.00M | $181.81M | $143.13M | $108.84M | $59.22M |
| Gross profit | $1.70B | $1.36B | $1.06B | $995.85M | $899.00M | $720.00M | $565.20M | $440.81M | $286.53M | $129.46M |
| Operating income | -$49.00M | -$144.00M | -$89.59M | $51.85M | $19.00M | -$27.00M | $112.32M | $117.12M | $77.72M | $16.85M |
| Net income | -$626.00M | -$740.00M | -$451.73M | -$110.12M | -$290.00M | -$315.00M | -$50.92M | -$359.81M | -$323.02M | -$129.25M |
| Research & development | $117.00M | $104.00M | $109.00M | $93.00M | $80.00M | $70.00M | $21.00M | $14.00M | $12.00M | $9.00M |
| Weighted-average diluted shares | shares 551.00M | shares 527.00M | Unavailable | shares 497.89M | shares 487.00M | shares 249.00M | Unavailable | shares 213.81M | shares 209.63M | shares 209.23M |
| Pretax income | -$564.00M | -$656.00M | -$466.86M | -$236.80M | -$242.00M | -$269.00M | -$29.13M | -$318.15M | -$282.87M | -$113.85M |
| Income tax expense | $62.00M | $84.00M | -$15.13M | -$126.68M | $48.00M | $46.00M | $21.79M | $41.66M | $40.15M | $15.40M |
| Diluted EPS | $-1.14 | $-1.40 | Unavailable | $-0.22 | $-0.60 | $-1.49 | Unavailable | $-1.82 | $-1.62 | $-0.62 |
| Selling, general & administrative | $238.00M | $233.00M | $202.17M | $196.52M | $210.00M | $186.00M | $53.16M | $38.18M | $25.93M | $19.74M |
| General & administrative | $178.00M | $164.00M | $150.16M | $151.88M | $174.00M | $175.00M | $47.93M | $33.63M | $21.75M | $15.69M |
| Selling & marketing | $60.00M | $69.00M | $52.01M | $44.64M | $36.00M | $11.00M | $5.22M | $4.55M | $4.17M | $4.05M |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.52B | $2.24B | $3.13B | $1.89B | $1.15B | $1.28B | $1.36B | $1.36B | $1.03B | $1.31B |
| Total assets | $77.07B | $55.57B | $49.30B | $32.91B | $26.24B | $21.86B | $17.83B | Unavailable | Unavailable | Unavailable |
| Current assets | $9.52B | $5.61B | $7.49B | $4.73B | $3.95B | $3.10B | $1.92B | Unavailable | Unavailable | Unavailable |
| Total liabilities | $72.05B | $50.81B | $45.97B | $29.03B | $22.42B | $18.79B | $16.52B | Unavailable | Unavailable | Unavailable |
| Current liabilities | $20.92B | $17.82B | $16.44B | $9.71B | $7.56B | $7.13B | $4.96B | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $5.02B | $4.76B | $3.34B | $3.88B | $2.66B | $1.91B | -$414.00M | -$344.03M | -$1.04B | -$715.56M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $1.72B | $1.72B | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $2.54B | $2.12B | $3.17B | $1.66B | $1.93B | $1.06B | $417.00M | Unavailable | Unavailable | Unavailable |
| Goodwill | $1.10B | $1.10B | $1.10B | $829.98M | $812.97M | $19.54M | $20.00M | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | $17.31B | $14.66B | $10.32B | $7.42B | $4.94B | $5.46B | Unavailable | Unavailable | Unavailable |
| Accounts payable | $3.63B | $3.37B | $1.62B | $1.16B | $1.23B | $1.24B | $868.00M | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $679.00M | $2.98B | $1.56B | $1.69B | -$251.00M | $61.00M | $186.56M | $641.22M | -$117.82M | $2.04B |
| Capital expenditures | $6.42B | $7.70B | $4.06B | $2.39B | $2.45B | $1.41B | $3.50B | $1.22B | $2.25B | $1.74B |
| Investing cash flow | -$7.17B | -$7.71B | -$3.93B | -$2.47B | -$2.44B | -$1.43B | -$3.46B | -$1.17B | -$2.25B | -$1.77B |
| Financing cash flow | $10.07B | $3.91B | $3.53B | $1.70B | $2.23B | $1.85B | $3.39B | $1.21B | $1.94B | $919.50M |
| Net change in cash | $3.58B | -$810.00M | $1.16B | $913.86M | -$463.00M | $482.00M | $113.02M | $682.15M | -$427.47M | $1.19B |
| Stock-based compensation | $165.00M | $153.00M | $156.59M | $144.41M | $145.00M | $184.00M | $7.53M | $7.62M | $7.66M | $8.19M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $1.39B | $1.15B | $820.54M | $630.46M | $560.00M | $443.00M | $365.01M | $254.02M | $164.46M | $79.51M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$5.74B | -$4.71B | -$2.50B | -$700.19M | -$2.70B | -$1.35B | -$3.31B | -$573.93M | -$2.36B | $297.10M |
| Gross margin | 65.9% | 65.5% | 67.6% | 73.0% | 74.2% | 73.3% | 75.7% | 75.5% | 72.5% | 68.6% |
| Operating margin | -1.9% | -6.9% | -5.7% | 3.8% | 1.6% | -2.7% | 15.0% | 20.1% | 19.7% | 8.9% |
| FCF margin | -223.0% | -226.7% | -159.1% | -51.3% | -223.1% | -137.1% | -443.3% | -98.3% | -598.2% | 157.5% |
| SBC / revenue | 6.4% | 7.4% | 10.0% | 10.6% | 12.0% | 18.7% | 1.0% | 1.3% | 1.9% | 4.3% |
| Current ratio | 0.46x | 0.31x | 0.46x | 0.49x | 0.52x | 0.44x | 0.39x | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | 112.5% | 111.6% | 110.4% | 133.7% | 206.5% | 420.4% | Unavailable | Unavailable | Unavailable | Unavailable |
| Net margin | -24.3% | Unavailable | -28.7% | -8.1% | -23.9% | Unavailable | -6.8% | -61.6% | Unavailable | Unavailable |
| R&D / revenue | 4.5% | 5.0% | 6.9% | 6.8% | 6.6% | 7.1% | 2.8% | 2.4% | 3.0% | 4.8% |
| CapEx / revenue | 249.4% | 370.3% | 258.3% | 175.1% | 202.4% | 143.3% | 468.2% | 208.1% | 568.4% | 923.2% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | 2.66x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CRWV in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-03-02View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2025-03-31
Difference 558718000 exceeds tolerance 21860383.000. Presentation or filing-vintage differences need review.